| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |